7/26/19 SHR # 2380 : Peptides That Help Resolve Stroke, TBI & CTE

By Elizabeth F. Yurth, MD | Peptides

Mar 27

Over 700,000 people suffer a stroke ever year. Add to that 2.5 million who suffer Traumatic Brain Injuries. Both of these may result in Chronic Encephalopathy – a degeneration of the brain tissue. Physicians have little in their toolbox to halt or reverse the collateral damage done to the brain. Now there are peptides than may not only stop the degenerative progression, but reverse and resolve the damage and allow for the restoration of all faculties.

Listen to this Podcast

Contact Us!

Questions About Peptides?

Boulder Longevity Institute is home to the nation's 1st Medically Managed Peptide Program for Human Optimization. If you're interested in learning more, give us a call today. (303)443-0848

About the Author

Elizabeth Yurth, MD is the Medical Director of the Boulder Longevity Institute which she co-founded in 2006. Dr. Yurth is double board-certified in Physical Medicine & Rehabilitation and Anti-Aging/Regenerative Medicine. As a specialist in Sports, Spine, and Regenerative Medicine, Dr. Yurth has a Stanford-affiliated Fellowship in Sports and Spine Medicine, and a dual-Fellowship in Anti-Aging and Regenerative Medicine (FAARM) and Anti-Aging, Regenerative and Functional Medicine (FAARFM) through the American Academy of Anti-Aging Medicine (A4M). Dr. Yurth is a faculty member and one of the 25 mastermind physician fellows in SSRP (Seeds Scientific Research and Performance) which allows her to stay abreast and teach others in the emerging field of cellular medicine. An active athlete herself, Dr. Yurth has worked with numerous sports teams at both the collegiate and professional levels. Presently she consults with high-level athletes from across the country to help aid recovery and optimize performance. Dr. Yurth resides in Boulder, Colorado with her husband and five children.